COVID-19
WHO backs AstraZeneca vaccine against South African variant
February 9, 2021Manufacturing and Production COVID-19, WHO, vaccines
World health officials have moved to ease concerns over the efficacy of the Oxford University-AstraZeneca vaccine against new variants of …
CureVac enters collaboration with UK government on coronavirus variant vaccines
February 8, 2021Sales and Marketing COVID-19, CureVac
CureVac has entered a collaboration with the UK government to develop and manufacture potential vaccine candidates against coronavirus variants, with …
South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns
February 8, 2021Sales and Marketing AstraZeneca, COVID-19
AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …
South Korea approves Celltrion’s COVID-19 treatment Regdanvimab for emergency use
February 8, 2021Sales and Marketing COVID-19, celltrion
The South Korean Ministry of Food and Drug Safety (MFDS) has granted a conditional marketing authorisation (CMA) for the emergency …
Pharmafile.com’s top 10 news stories of the week
February 5, 2021Medical Communications COVID-19
In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …
New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October
February 5, 2021Medical Communications AstraZeneca, COVID-19
Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …
Pfizer withdraws application for emergency vaccine authorisation in India
February 5, 2021Medical Communications COVID-19, Pfizer
Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …
Pharmafile.com’s weekly COVID-19 news round-up
February 3, 2021Research and Development COVID-19
The past week has seen mostly positive COVID-19 vaccine developments; Pfizer has confirmed its jab is effective against both the …
Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says
February 3, 2021Research and Development AstraZeneca, COVID-19
A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …
GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine
February 3, 2021Research and Development COVID-19, CureVac, GlaxoSmithKline
GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …
Johnson & Johnson’s single-shot COVID-19 vaccine 85% effective
February 1, 2021Sales and Marketing COVID-19, Johnson & Johnson, vaccines
Johnson & Johnson has announced that its COVID-19 vaccine candidate is 85% effective in preventing serious symptoms of the disease, …
AstraZeneca COVID-19 vaccine not for over 65s, German health body says
January 29, 2021Medical Communications AstraZeneca, COVID-19
Germany’s main public health body has recommended that AstraZeneca’s COVID-19 vaccine is only administered to those aged between 18 and …
Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial
January 29, 2021Medical Communications COVID-19, Novavax
Novavax has announced that its COVID-19 vaccine candidate, NVX-CoV2373, demonstrated an efficacy of 89.3% in its UK Phase III trial. …
Valneva begins production of its COVID-19 vaccine
January 28, 2021COVID-19, Valneva
Valneva, a specialty vaccine company focused on the prevention of infectious diseases with significant unmet medical needs, has commenced production …
AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy
January 26, 2021Manufacturing and Production AstraZeneca, COVID-19
AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
